In 2023, antibacterial medicine sales in Türkiye stood at 14.2 USD PPP per capita. Forecasts predict a steady decline over the next five years with values decreasing to 13.9 in 2024, 13.6 in 2025, 13.3 in 2026, 13.0 in 2027, and 12.8 in 2028. Year-on-year variations show modest decreases of approximately 2-2.5% annually. The Compound Annual Growth Rate (CAGR) over the forecasted period is around -2.1%, indicating a gradual but consistent reduction in sales.
Future trends to watch for include the growing impact of antimicrobial stewardship programs aimed at reducing unnecessary prescriptions, increasing efforts towards infection prevention, and the potential introduction of new, more effective treatments that might shift the market dynamics. Monitoring regulatory changes and market entry of generic drugs will also be crucial for accurate forecasting.
